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Abstract
Surgery for brain cancer is a major problem in neurosurgery. The diffuse infiltration into the
surrounding normal brain by these tumors makes their accurate identification by the naked
eye difficult. Since surgery is the common treatment for brain cancer, an accurate radical
resection of the tumor leads to improved survival rates for patients. However, the identifica-
tion of the tumor boundaries during surgery is challenging. Hyperspectral imaging is a non-
contact, non-ionizing and non-invasive technique suitable for medical diagnosis. This study
presents the development of a novel classification method taking into account the spatial
and spectral characteristics of the hyperspectral images to help neurosurgeons to accu-
rately determine the tumor boundaries in surgical-time during the resection, avoiding exces-
sive excision of normal tissue or unintentionally leaving residual tumor. The algorithm
proposed in this study to approach an efficient solution consists of a hybrid framework that
combines both supervised and unsupervised machine learning methods. Firstly, a super-
vised pixel-wise classification using a Support Vector Machine classifier is performed. The
generated classification map is spatially homogenized using a one-band representation of
the HS cube, employing the Fixed Reference t-Stochastic Neighbors Embedding dimen-
sional reduction algorithm, and performing a K-Nearest Neighbors filtering. The information
generated by the supervised stage is combined with a segmentation map obtained via unsu-
pervised clustering employing a Hierarchical K-Means algorithm. The fusion is performed
using a majority voting approach that associates each cluster with a certain class. To
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evaluate the proposed approach, five hyperspectral images of surface of the brain affected
by glioblastoma tumor in vivo from five different patients have been used. The final classifi-
cation maps obtained have been analyzed and validated by specialists. These preliminary
results are promising, obtaining an accurate delineation of the tumor area.
Introduction
In addition to radiotherapy and chemotherapy, surgery is one of the major treatment options
for brain tumors [1]. However, because brain tumors infiltrate and diffuse into the surround-
ing normal brain, the surgeon’s naked eye is often unable to accurately distinguish between
the tumor and normal brain tissue. Inevitably, tumor tissue is either unintentionally left
behind during surgery or too much normal brain tissue is taken out. Studies have shown that
tumor tissue left behind during surgery is the most common cause of tumor recurrence and is
a major cause of morbidity and mortality [2–4]. On the other hand, over-resection of brain
tumor tissues has also been shown to cause permanent neurological deficits that affect patients’
quality of life [5]. Intra-operative neuro-navigation, intra-operative Magnetic Resonance
Imaging (iMRI) and fluorescent tumor markers such as 5-aminolevulinic acid (5-ALA) have
been developed as adjuncts to surgery to help with brain tumor delineation. Although these
adjuncts have improved the accuracy of brain tumor resections, they have a number of limita-
tions. Neuro-navigation is rendered inaccurate at locating tumor margins due to brain shift
and changes in tumor volume that occurs during resections [6,7]. Intra-operative Magnetic
Resonance Imaging was developed as a solution to intra-operative brain shift capable tumor
margin mapping intra-operatively. However, this has been found to have poor spatial resolu-
tion, to largely extend the surgery time and it is very expensive [8]. Due to the time to stop sur-
gery and obtain scans it is better regarded as providing at most a few images at certain
timepoints rather than a continuous real time image. Fluorescent tumor markers such as
5-aminolevulinic acid (5-ALA) are excellent at identifying tumors but can only be used for
high grade tumors, produce important knock-on effects and are poor at defining tumor mar-
gins mainly due to the diffuse nature of brain tumors [9,10].
Therefore, despite the improvement in surgery and technology, we are still unable to accu-
rately define brain tumor margins. Label free, non-ionizing imaging modalities that rely on
intrinsic properties of tumors or normal brain could be a potential solution to the above prob-
lem. Hyperspectral Imaging (HSI) is a form of imaging spectroscopy that captures spectral and
spatial data beyond the limited three electromagnetic bands of the human eye [11]. It produces
a three-dimensional image with each pixel containing spectral information of the captured
scene. The spectral information of each pixel correlates to the chemical composition of the
scene. This technology has relevance in the medical field because it has been proven that the
interaction between electronic radiation and tissue carries useful information for diagnosis
purposes [12]. In the field of early detection of tumor, HSI is shown as a promising technology
due to its non-invasive interaction with tissue and its capability to rapidly acquire and analyze
data, obtaining useful information for diagnosis purposes. In recent years, the number of stud-
ies using HSI analysis for cancer diagnosis has rapidly increased. The main differences be-
tween studies are in the acquisition system setup as in [13], the nature of the samples (in-vivo,
ex-vivo or in-vitro) the disease studied (prostate [14], ovaries [15], breast [16], tongue cancer
[17], skin and lung cancer [18] or oral cancer [19]), and the applied processing methods to
analyze the HS data (as in the application to larynx cancer [20]).
Hyperspectral brain cancer imaging classification
PLOS ONE | https://doi.org/10.1371/journal.pone.0193721 March 19, 2018 2 / 27
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
One of the most active research groups in biomedical applications of HSI is led by Professor
Baowei Fei, from the Department of Biomedical Engineer at Emory University. The main
characteristics of the HSI research performed by this group can be summarized as follows.
Their experiments explore cancer diseases in animal subjects. Until now, they have analyzed
prostate cancer [21] and head and neck cancer [22]. Moreover, they usually work using an
acquisition system based on LCTFs (Liquid Crystal Tunable Filters) in the VNIR spectral
range, from 400 nm to 1000 nm. Most of their experiments have been carried out in-vivo dur-
ing surgical procedures. Their research has exhaustively analyzed which pre-processing tech-
niques are more suitable to compensate the variations of the environmental conditions during
the acquisition inside an operating theatre [23,24]. The processing techniques employed by
this research group in order to extract useful information from the hyperspectral (HS) cubes,
vary depending on each research study, but each new publication presents novel and sophisti-
cated methods such as a Minimum-Spanning Forest classification [25].
In this pilot study, we investigate whether intra-operative hyperspectral imaging can iden-
tify and delineate brain tumors. This work is framed in a European collaborative project
funded by the Research Executive Agency (REA) called HELICoiD (HyperEspectraL Imaging
Cancer Detection) formed by four universities, two university hospitals and three leading
industry partners.
Materials and methods
Intra-operative hyperspectral acquisition system
The hyperspectral acquisition system employed in this work is called the HELICoiD demon-
strator [26]. The system is composed by a hyperspectral pushbroom camera manufactured by
HeadWall Photonics: the Hyperspec1 VNIR A-Series model. The VNIR camera covers the
spectral range from 400 nm to 1000 nm, with a spectral resolution of 2–3 nm, being able to
capture 826 spectral bands and 1004 spatial pixels. This device integrates a Silicon CCD detec-
tor array with a minimum frame rate of 90 fps, understanding in this context a frame as a line
of 1004 pixels and 826 spectral bands. The lens used in this camera is a Xenoplan 1.4 with 22.5
mm of focal length and a broadband coating for the spectral range of 400 nm to 1000 nm. The
camera is attached in a scanning platform composed by a stepper motor and a spindle capable
of covering an effective area of 230 mm. This scanning platform is required to acquire the sec-
ond spatial dimension as the pushbroom camera can only sample a single line. The setup uses
an illumination system composed by a Quartz-Tungsten-Halogen (QTH) lamp connected to a
cold light emitter via fiber optic that allows achieving cold illumination over the brain surface.
This is required in order to avoid high temperatures produced by the QTH lamp over the
brain surface. Fig 1 shows the intra-operative hyperspectral acquisition system being used dur-
ing a neurosurgical operation.
In-vivo human brain hyperspectral image database
A set of five in-vivo brain surface HS images, captured using the previously described acquisi-
tion system, has been used for this research. These images belong to adult patients undergoing
craniotomy for resection of intra-axial brain tumor. Images have been obtained at the Univer-
sity Hospital Doctor Negrin of Las Palmas de Gran Canaria (Spain) and at the University Hos-
pital of Southampton (United Kingdom) from five different patients with confirmed grade IV
glioblastoma tumor on histopathology. The study protocol and consent procedures were
approved by the Comite´ E´tico de Investigacio´n Clı´nica-Comite´ de E´tica en la Investigacio´n
(CEIC/CEI) for the University Hospital Doctor Negrin and the National Research Ethics Ser-
vice (NRES) Committee South Central—Oxford C for the University Hospital of Southampton.
Hyperspectral brain cancer imaging classification
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Written informed consent was obtained from all subjects. The individual that appears in Fig 1
in this manuscript has given written informed consent (as outlined in PLOS consent form) to
publish these case details.
The procedure to acquire the in-vivo data during neurosurgical operations has been
described elsewhere and in summary is as follows. First, after performing the craniotomy and
durotomy, the neurosurgeons place some rubber ring markers over the brain surface where
they are confident that the tissue inside the markers is tumor or normal based on its macro-
scopic appearance and taking into account the information provided by the neuronavigator
from an MRI scan (Magnetic Resonance Image). In case of patient 1, two markers were placed
in the tumor area and one marker was placed over the healthy tissue. In cases of patients 2, 3
and 4, two markers were use, one placed over the tumor area and another one placed over the
normal tissue. Finally, in case of patient 5, no markers were used since the tumor was in a
deeper layer with respect to the normal tissue and it was clearly identified. After that, the oper-
ator of the acquisition system captures a HS image. Depending on the location of the tumor,
the images are acquired at various stages of the operation. In cases of patients 1, 2, 3 and 4, one
image was obtained immediately after the dura was removed since the tumor was superficially
Fig 1. Intra-operative hyperspectral acquisition system used during a neurosurgical procedure at the University Hospital Doctor Negrin of Las Palmas de
Gran Canaria.
https://doi.org/10.1371/journal.pone.0193721.g001
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located. In case of patient 5, the image was captured in an advanced stage of the tumor resec-
tion since the tumor was deep seated. Once the HS image is taken, the operating surgeon per-
forms a biopsy of the tissue located within the tumor tissue marker/s (in case of patient 1, 2, 3
and 4) or within the clearly identified tumor area (in case of patient 5). The resected tissue is
sent to the pathologists in order to confirm the presence or absence of tumor, and obtain the
specific histopathological diagnosis (grade and type of tumor). Since this technology cannot
penetrate into the tissue (in case of near infrared it can be 1 mm at most), the average size of
the resected sample of the tumor for pathological analysis is 0.5x0.5 mm and 0.2 mm depth.
Normal tissue markers are only used as a reference for the labelling process performed after
the operation has finished. It is not ethic to perform a biopsy of the tissue that is known to
belong to normal brain (it can produce damages in the undergoing patient outcomes).
Employing the histopathological information (from the tumor tissue samples) and the knowl-
edge of the operating surgeon (from the normal tissue samples), the labeling of the HS cubes is
performed to generate a gold standard dataset for the supervised classification stage of the
brain cancer detection algorithm.
The manual labeling of the HS data consists of visual identification of each sample by a spe-
cialist, which is time-consuming task and can introduce errors due to human intervention.
For this reason, a methodology for extracting the gold standard information from the HS
cubes, based on the Spectral Angle Mapper (SAM) algorithm, has been developed. The tool
developed for sample labeling has been designed using Matlab1 GUIDE application and mea-
sures the angle between two high dimensional vectors. This SAM classification is an automated
method for comparing the spectra of the pixels of a HS image with a well-known spectrum
obtained from a reference pixel. The tool was used by the corresponding operating surgeon
after the operation conclusion in order to generate the gold standard map for each image.
Four different classes were employed in this study: normal tissue, tumor tissue, blood vessel and
background. The procedure to obtain the gold standard map is as follows. First, the user loads
a HS cube to be labeled and selects a reference pixel, looking the synthetic RGB representation
of the HS cube, at the location where a biopsy is done (where the tumor marker is placed) or at
a location far enough from the tumor margins where the surgeon can be quite confident that
the tissue is abnormal (in the case of tumor labeling). In case of normal tissue, blood vessel
and background classes, the labeling is performed by the operating surgeon by selecting a ref-
erence pixel by naked eye based on their knowledge and experience. Then, the most similar
pixels to the selected reference pixel are highlighted, based on the SAM measurement, and the
user configures the threshold that varies the tolerances on the pixels selected. Once the user
considers that only the pixels belonging to one class are highlighted, the selected pixels are
assigned to that class. Fig 2 shows a screenshot of the HELICoiD Labelling Tool where the
labeling procedure of the blood vessel class has been done. On the left side of the image (Fig
2A), the synthetic RGB representation of the HS cube is shown. In the center (Fig 2B), the
SAM representation is presented, where only the pixels that have a spectral angle less than
0.08˚ respect to the selected reference pixel are highlighted. In this case, the reference pixel and
its correspondent SAM representation belongs to the blood vessel class. Finally, on the right
side of the image (Fig 2C), the gold standard map generated for patient 2 is shown, where
tumor tissue, normal tissue, blood vessels and background are represented in red, green, blue
and black colors respectively. Some sliders controls are presented in the labeling tool so as to
adjust the gamma of the synthetic RGB image, the overlapping transparency of the SAM
image over the synthetic RGB image and the threshold value. Employing this labeling tool, a
total of 44,555 spectral signatures was labeled. Table 1 summarizes the total number of labeled
spectral signatures generated for each class, the number of tumor biopsies performed and the
number of images captured for each patient. Summarizing, the reliability of the gold standard
Hyperspectral brain cancer imaging classification
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is guaranteed by the use of the intraoperative MRI Neuronavigation for placing the rubber
ring markers; the operating surgeon knowledge and experience for the labelling of the normal
tissues, blood vessels and background samples; and finally, the pathological analysis of the
resected tissue for the tumor labeling.
Brain cancer detection algorithm
The classification framework developed in this study aims to exploit both the spatial and spec-
tral features of the HS images. Fig 3 illustrates the scheme of this classification framework
based on five main steps: data pre-processing, dimensional reduction, spatial-spectral super-
vised classification, unsupervised clustering segmentation and hybrid classification. After cap-
turing the in-vivo brain surface HS cube (Fig 3A), the raw image is pre-processed in order to
homogenize the spectral signatures of each pixel (Fig 3B). After the pre-processed stage, the
golden standard employed for building the supervised classifier model is extracted by the spe-
cialists (Fig 3C) using the previously described labeling tool and the SVM classifier is trained
(Fig 3D). Once the SVM model is generated, it is used to perform the supervised pixel-wise
classification over the pre-processed HS cube (Fig 3E). Then, a spatial-spectral homogeniza-
tion is accomplished [27] using a KNN (K-Nearest Neighbor) filtering (Fig 3G), where a one-
Fig 2. Screenshot of the HELICoiD Labeling Tool.
https://doi.org/10.1371/journal.pone.0193721.g002
Table 1. Gold standard dataset for the supervised training process.
Patient ID #Captured Images #Tumor Biopsies Tissue Type (#pixels) Total
(#pixels)Normal Tissue Tumor Tissue Blood Vessel Background
1 1 2 2,295 1,221 1,331 630 5,477
2 1 1 4,516 855 8,697 1,685 15,753
3 1 1 1,251 2,046 4,089 696 8,082
4 1 1 1,842 3,655 1,513 2,625 9,635
5 1 1 977 1,221 907 2,503 5,608
Total (#pixels) 10,881 8,998 16,537 8,139 44,555
https://doi.org/10.1371/journal.pone.0193721.t001
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band representation of the HS cube is employed. The dimensionality reduction algorithm
used to obtain the one-band representation of the HS cube is the FR-t-SNE algorithm (Fig 3F).
This algorithm has been selected because it provides the best score along different HS images
compared to other dimensionality reduction algorithms [28]. Once the spatial-spectral
homogenization has been performed, a filtered classification map is available. In order to
obtain the final classification map, the spatial-spectral supervised classification map is com-
bined with a segmentation map obtained via unsupervised hierarchical clustering (Fig 3H)
using a Majority Voting (MV) approach [29] (Fig 3I).
Data pre-processing. After the acquisition of the in-vivo brain surface HS cube (Fig 3A),
a pre-processing chain, already explained in [30], is applied to the HS cube to homogenize the
spectral signatures of each pixel (Fig 3B) and to reduce the dimensionality of the HS image
without losing the main spectral information contained on it. This pre-processing chain con-
sists of five steps. The first step performs a radiometric calibration of the raw spectral signature
of each pixel using the black and white reference images acquired by the acquisition system
inside the operating theatre with the same illumination conditions that the image that will be
captured. The white reference image is obtained using a standard white reference tile and the
dark reference image is acquired by keeping the camera shutter closed. Fig 4A and 4B show an
example of a single raw spectral signature and the calibrated spectral signature of a grade IV
glioblastoma tumor respectively. The second step applies noise filtering using the first stage of
the HySIME algorithm where a function called Hyperspectral Noise Estimation infers the
noise in the HS data, by assuming that the reflectance at a given band is well modeled by a lin-
ear regression on the remaining bands. Fig 4C plots the spectral signature after the HySIME
noise filtering application. In the third step, the spectral bands from the lowest and highest
bands are removed due to their low SNR because of the limited performance of the CCD sen-
sor in these ranges. Bands from 0 to 50 and from 750 to 826 are removed. After the extreme
noise band removing step, the spectral signatures are reduced in bands through spectral aver-
aging due to the information redundancy between contiguous bands. The reduced HS cube is
formed of 129 spectral bands. Finally, the last step of the pre-processing chain applies nor-
malization over the samples to avoid the different radiation intensities of each pixel produced
by the non-uniform surface of the brain. Fig 4D illustrates the final pre-processed spectral
signature.
Fig 3. Brain cancer detection and delimitation algorithm overview diagram. (A) HS cube of in-vivo brain surface. (B) Pre-processing stage of the algorithm. (C)
Database of labeling samples generation. (D) SVM model training process employing the labeled samples dataset. (E), (F) and (G) Algorithms that conform the spatial-
spectral supervised classification stage. (H) and (I) Algorithms that generate the unsupervised segmentation map and the final HELICoiD TMD map, respectively.
https://doi.org/10.1371/journal.pone.0193721.g003
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Dimensional reduction. From an information-processing point of view, the intrinsic
dimensionality of HS images can be significantly reduced before subsequent image characteri-
zation steps are applied. Dimensionality reduction maps high-dimensional data into a mean-
ingful representation of reduced dimensional space so that the observed properties of the
initial data are still preserved in the low dimensional space. Since the intrinsic dimension, as
well as the geometry of the initial data, is unknown, dimensionality reduction, in general, is an
ill-posed problem that can only be solved by assuming certain data properties.
Thus far, many algorithms for dimensionality reduction have been developed in literature
[31]. Principal Component Analysis (PCA) [32] is one of the most popular linear techniques
for dimensionality reduction. It maps the data preserving as much as possible their variance.
However, PCA has two important limitations: it is based on a global property–the variance of
the data–and it is a linear technique. Non-linear methods have the advantage that can deal bet-
ter with complex real world data. Techniques such as Isomap [33], Locally Linear Embedding
Fig 4. Spectral signature of a grade IV glioblastoma tumor tissue. (A) Raw spectral signature. (B) Calibrated spectral signature. (C) HySIME filtered spectral
signature. (D) Final pre-processed spectral signature.
https://doi.org/10.1371/journal.pone.0193721.g004
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(LLE) [34], Hessian [35] and Laplacian [36] are examples of non-linear methods. In this paper,
the Fixed Reference t-Distributed Stochastic Neighbors Embedding (FR-t-SNE) algorithm
proposed in [28] is used as dimensional reduction for the HS images.
FR-t-SNE is an extension of the t-Distributed Stochastic Neighbors Embedding (t-SNE)
[37] that is a nonlinear technique well suited for embedding high-dimensional data into a low
dimensional space. As stated in [28], embedding a HS image using t-SNE may not guarantee
consistent results since, at each dimensional reduction process of a new image, the random
nature of the t-SNE can create embedded representations that are not persistent. Therefore, it
can happen that similar tissues will be represented with different low dimensional representa-
tions across different images. This makes subsequent tissue characterization difficult. This
problem is mainly generated by the lack of a fixed coordinate system, which does not allow the
comparison of the embedded results across different tissue samples [38], FR-t-SNE tries to
overcome these limitations by using a learning process aimed at finding a fixed reference coor-
dinate system. FR-t-SNE is divided in three main steps: in Step 1, an optimal reference system
is fixed to maintain a consistent manifold embedding along with all the images and circumvent
the lack of a fixed coordinate system. In Step 2, the manifold is gradually tested on the training
set using the predefined fixed reference. Finally, in the last step, a HS image is embedded effi-
ciently. A KNN classification algorithm is used to obtain the low vector representation of each
high dimensional vector after all the training images are processed and the manifold discov-
ered. This KNN classifier will use a lookup table, containing the values of the learned reference
coordinates to predict the embedded value of each sample in each new HS image.
In the proposed brain cancer detection algorithm, FR-t-SNE is employed to obtain a one-
band representation of the pre-processed HS cube with 750 bands (without applying the band
averaging step in the pre-processing chain).
Spatial-spectral supervised classification. Support Vector Machines (SVMs) are kernel-
based supervised algorithms that have been extensively used for classification tasks. As a rele-
vant example, a variant of the SVM classifier, called Fuzzy SVM classifier, was employed in the
development of an emotion recognition system based on facial expression images, obtaining
overall accuracy results of 96.77±0.10% [39]. In the HSI field, SVMs provide good performance
for classifying this type of data when a limited number of training samples are available [40].
Due to its strong theoretical foundations, good generalization capabilities, low sensitivity to
the problem of dimensionality and the ability to find optimal solutions, SVMs are usually
selected by many researchers over other classification paradigms for classifying HS images
[12]. In the medical field, SVMs have been used to detect multiple sclerosis subjects employing
stationary wavelet entropy to extract features from magnetic resonance images used as input
of the SVM classifier [41]. Furthermore, the same technique combined with a directed acyclic
graph method has been used to diagnose unilateral hearing loss in structural MRI [42], dem-
onstrating that the SVM algorithm is a reliable candidate to work with medical images. In
medical HSI, SVMs have been already used to classify several types of cancer, including pros-
tate [14], lung tissue and lymph nodes [21] skin tumors [43,44], tongue [45] and colon [46].
On the other hand, during the development of this research project, some studies have been
carried out using SVMs to classify hyperspectral in-vivo images of human brain affected by
cancer [26,30]. For the research presented in this paper, LIBSVM [47] has been used for sup-
port vector classification.
SVM algorithm requires a confident labeled dataset in order to train the model that will be
used to classify the input data. In this work, the labeled dataset of in-vivo brain samples that is
used to train the SVMs has been created by combining the efforts of neurosurgeons and
pathologist, as it has been previously described. Before explaining the methodology employed
for performing a supervised classification over the available HS data, some considerations have
Hyperspectral brain cancer imaging classification
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to be taken into account. Due to the impossibility of having a way to extract the labeled infor-
mation from all the pixels in a HS cube of brain tissue, there are two ways of measuring the
performance of the generated supervised models. For the available labeled dataset, it is possible
to use standard metrics in order to measure the accuracy provided by the model when classify-
ing unseen data. Nevertheless, for evaluating a supervised model applied to a whole HS cube
(where not all pixels have been labeled) only the visual evaluation of an expert is possible. The
methodology for evaluating the supervised classifiers in a quantitative way is as follows: first,
we use the labeled information corresponding to the dataset, and then we apply a 10-fold cross
validation in order to measure the performance of the model. The quantitative evaluation met-
rics used for this purpose has been sensitivity, specificity and overall accuracy metrics, and will
be defined later in this paper.
Once the quantitative metrics have been obtained, the previously trained SVM classifier is
used to classify a whole HS cube, and then it is evaluated by neurosurgeons in order to analyze
the quality of the algorithm in distinguishing different types of tissues, materials or substances.
In order to include the spatial features of the HS images, a spatial homogenization is applied to
improve the supervised classification results by incorporating the neighborhood information
of each pixel into the classification chain. The algorithm proposed in [27], which refines the
pixel-wise classification probability map using a KNN filtering on non-local neighborhoods of
a pixel, has been used. The algorithm has shown competitive classification accuracy results
compared with other state-of-art spatial-spectral classification approaches [27]. The algorithm
requires two inputs: the probability maps or confidence scores obtained from the supervised
classifier (P) and the guidance image (I) (which is usually a one-band representation of the
input HS image). The spatial-spectral feature vector is defined in Eq 1, where I is the normal-
ized pixel value (spectrum) at location i and l(i), h(i) are the normalized longitude and latitude
of the pixel i. The output of the KNN-filtering is given by Eq 2, where Ni refers to the K-nearest
neighbors of the pixel i found in the feature space F(i). It can be seen that at λ = 0 there is no
spatial information, while when non-zero it captures the spatial information of pixel i given by
l(i) and h(i).
FðiÞ ¼ ðIðiÞ; llðiÞ; lhðiÞÞ ð1Þ
O ið Þ ¼
P
PðjÞ
K
; j 2 Ni ð2Þ
When λ is set to zero, the spatial coordinates are not considered in the KNN filtering pro-
cess, and when the value of λ increases, the classification results tend to be oversmoothed,
decreasing the accuracy of the classification results. The parameter K has a similar influence in
the classification results: when the K value is high, the filtering method oversmooths the classi-
fication results, worsening the accuracy of the classification results. In this approach, it is not
possible to provide a quantitative measure of the influence of K and λ parameters, due to the
absence of a complete golden standard map. Nevertheless, the influence of these parameters in
the generation of the classification maps has been studied. As mentioned before, large values
of K or λ tends to oversmooth the obtained classification maps. Several executions of the KNN
filtering were performed employing different values of K (5, 10, 20, 40 and 60) and λ (0, 1, 5,
10 and 100). Fig 5 shows the filtered classification maps of the patient 2 using different values
of K and λ. In both cases, small values of K and λ result in a mix of small classes that do not
represent the real distribution of the tissues. On the other hand, large values of K and λ tend to
oversmooth the classes. After a visual inspection of the results by the specialists (neurosur-
geons), the final values of K and λ chosen for this study were K = 40 and λ = 1. These values
Hyperspectral brain cancer imaging classification
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generate a filtered map where the different classes are homogenized enough without over-
smoothing the classification result (Fig 5D and 5G).
In this study, the probability maps are obtained from the confidence scores of the SVM clas-
sification result, while the guidance image is obtained by calculating the one band representa-
tion of the HS cube by performing a dimensionality reduction using the FR-t-SNE algorithm
[28].
Unsupervised clustering segmentation. Hierarchical clustering algorithms are able to
explore the different subspaces presented in a HS cube. Each cluster centroid represents a spec-
tra corresponding to a material in the scene, while the membership functions provide the
weights for these spectra. Some works based on hyperspectral analysis for medical applications
use unsupervised clustering as part of the classification algorithm, such as for colon tissue cell
classification [48] or laryngeal cancer detection [49]. Unsupervised clustering provides a hier-
archy of segmentations/clusters and its correspondent cluster centroid. Although it does not
provide any discriminant feature by itself, it could be used delineate the boundaries of the dif-
ferent spectral regions presented in the HS image.
The unsupervised stage of the algorithm is based on a clustering method [50]. This method
provides a segmentation map where all the different tissues, materials or substances found in
the HS image are grouped forming clusters that have similar spectral characteristics. Three dif-
ferent clustering algorithms have been applied to the available HS images differentiating
between 24 clusters: Hierarchical rank-2 non-Negative Matrix Factorization (H2NMF) [50],
Hierarchical K-Means (HKM) and Hierarchical Spherical K-Means (HSKM) [51]. After a
visual evaluation of the resulting maps by the specialists, it was found that all clustering meth-
ods provided useful information about the different tissues, materials and substances that were
presented in the scene. Due to the fact that all three clustering methods provided similar infor-
mation, HKM was selected in this study since it had the lower computational cost providing
similar results. In the context of this work, the clustering process provides a good delimitation
of the different areas presented in the image that should be identified by a specialist or by an
automatic process, i.e., supervised classification. For this reason, a method to merge the results
from the supervised and unsupervised stages of the brain cancer algorithm is required to
obtain the final classification map.
Fig 5. KNN filtered maps obtained with different K and λ values. (A), (B), (C), (D) and (E) filtered maps obtained with K equal to 5, 10, 20, 40, and 60, while
keeping λ value fixed to 1. (F), (G), (H), (I) and (J) filtered maps obtained with λ equal to 0, 1, 5, 10, and 100, while keeping K value fixed to 40.
https://doi.org/10.1371/journal.pone.0193721.g005
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Hybrid classification. In the previous sections, the advantages of supervised and unsuper-
vised learning methods have been introduced. On the one hand, supervised learning can infer
the knowledge previously provided by neurosurgeons and pathologists, but it can poorly pro-
vide a good delimitation of the tumor area. On the other hand, the unsupervised clustering
results provide a good association of similar pixels, but each cluster is semantically meaning-
less. In order to solve this problem, an algorithm for merging these two sources of information
has been employed. This hybrid algorithm has been previously used in hyperspectral imaging
[29], and consists of a technique that merges the information from a supervised classification
map and an unsupervised segmentation map (Fig 6). In the first step of this algorithm, the seg-
mentation map and the supervised classification map are calculated independently from the
same pre-processed HS cube. Once both maps have been obtained, the information is merged
using the majority voting algorithm. For each cluster found by the clustering algorithm, all
Fig 6. Hybrid classification example based on a majority voting technique. The unsupervised segmentation map
and the supervised classification maps are merged using the majority voting method.
https://doi.org/10.1371/journal.pone.0193721.g006
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pixels are assigned to the most frequent class in each region in the supervised classification
map. The combination of the supervised classification with the segmentation map provides
some advantages. On the one hand, the unsupervised segmentation maps obtained with the
clustering process have shown good capability in finding homogeneous spatial data structures
from the HS cube. However, it does not provide any identification of the tissue, material or
substance that the cluster belongs to. On the other hand, the supervised classification approach
employs the diagnosis information provided by medical doctors (neurosurgeons and patholo-
gists) to generate a classification map where each pixel of the image has been assigned to a cer-
tain class. However, the amount of labeled information is limited. Using the previously
described MV algorithm, the strengths of each method are exploited. As stated in [29], over-
segmentation (different clusters correspond to the same class) is not a crucial problem, but
undersegmentation is not desired. Fig 6 graphically represents the method of the hybrid algo-
rithm where an unsupervised map, composed by four different clusters that have no semantic
meaning, is merged with a supervised classification map, composed by four different classes
that have histological meaning. The final hybrid classification map represents each pixel within
a certain class (identified by the supervised classification algorithm) grouped taking into
account the clusters obtained by the unsupervised segmentation map (that delimitates the bor-
ders of each cluster region).
Brain cancer detection algorithm acceleration
As far as the actual system implementation concerns, a preliminary demonstrator has been
built using a modified version of the brain cancer detection algorithm [52]. To implement this
application, both a computer and a hardware accelerator–MPPA-256-N, an architecture that
gathers 256 processing units [53]–have been employed. On the one hand, the common stages
of the application–data pre-processing and hybrid classification–and the unsupervised classifi-
cation are executed on the computer that manages the hyperspectral cameras. On the other
hand, the spatial-spectral supervised classification is mapped to a hardware accelerator. The
rationale behind is the high computational load of the stage. For this preliminary demonstrator
[52], the spatial-spectral stage has been modified. Additionally, as the system aims at building
a generic classification model to assist neurosurgeons, without adding new samples, the classi-
fication model generation stage could be removed from the processing chain and consider it as
a configuration step. Therefore, the processing chain would be composed of four stages: 1) a
pre-processing of the HS cube; 2) a spatial-spectral supervised classification; 3) an unsuper-
vised classification; 4) a hybrid classification.
Evaluation metrics
The methodology for evaluating the supervised classifiers in a quantitative way is as follows:
firstly, the labeled information corresponding to a simulation was used, and then, a 10-fold
cross validation was applied in order to measure the performance of the model. The quantita-
tive evaluation metrics used for this purpose are sensitivity, specificity and overall accuracy
metrics. These are calculated from the following conditions:
• True Positive (TP): Correctly detected conditions. The result of the test is positive and the
actual value of the classification is positive.
• False Positive (FP): Incorrectly detected conditions. The result of the test is negative and the
actual value of the classification is positive.
• True Negative (TN): Correctly rejected conditions. The result of the test is negative and the
actual value of the classification is negative.
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• False Negative (FN): Incorrectly rejected conditions. The result of the test is positive and the
actual value of the classification is negative.
Sensitivity is the proportion of the actual positives that are correctly identified as positives
by the classifier (see Eq 3). Specificity is the proportion of the actual negatives that the classifier
successfully valuates as negative (see Eq 4). Overall Accuracy refers to the ability of the model
to correctly predict the class label of new or previously unseen data (see Eq 5).
Sensitivity ¼
TP
TPþ FN
ð3Þ
Specificity ¼
TN
TN þ FP
ð4Þ
Accuracy ¼
TPþ TN
TPþ FPþ TN þ FN
ð5Þ
Once the quantitative metrics have been obtained, the previously trained SVM classifier is
used to classify a whole HS cube, and the result is evaluated by neurosurgeons in order to ana-
lyze the quality of the algorithm in distinguishing different types of tissues, materials or
substances.
Experimental results
Hyperspectral imaging can distinguish between tumor and normal tissue
pixels by their spectra
Fig 7A and 7B show the mean and variances of the pre-processed spectral signatures of the
tumor tissue, normal tissue and blood vessel labeled pixels obtained from the golden standard
database of patient 1 and 2, respectively. As it can be seen in this figure, the shape of the signa-
ture depends on the tissue heterogeneity, especially in the tumor class. There are some similar-
ities between the spectral signature of the blood vessel class and the tumor class that could
Fig 7. Mean and variances of the pre-processed spectral signatures of the tumor, normal and blood vessel classes of the labeled pixels from patient 1 (A) and patient 2
(B), represented in red, black and blue color respectively.
https://doi.org/10.1371/journal.pone.0193721.g007
Hyperspectral brain cancer imaging classification
PLOS ONE | https://doi.org/10.1371/journal.pone.0193721 March 19, 2018 14 / 27
produce some misclassifications, as it will be explained later. However, it is possible to see that
the differences between the normal class and the tumor class are remarkable. These differences
will ensure a successful classification of the normal and tumor pixels by the supervised classi-
fier. In order to demonstrate that the use of a supervised classifier will achieve a reliable differ-
entiation between the labeled pixels that conforms the golden standard database, these pixels
have been spectrally analyzed employing an SVM classifier. Afterwards, the SVM model gener-
ated using the golden standard database for each patient was employed to classify the entire
HS cube of this patient. As it was previously mentioned, the golden standard information was
extracted from the HS data using a specific tool developed to this end.
In order to measure the supervised classifier performance and to select the optimal configu-
ration of the SVM model, a three-way cross validation has been employed. Linear, Radial Basis
Function (RBF), polynomial and Sigmoid kernels have been tested and compared. Fig 8A
shows the overall accuracy classification results obtained in the experiments comparing the
four SVM kernels with the default parameters, using the labeled dataset for each patient indi-
vidually and performing the three-way cross validation. S1–S4 Tables present the confusion
matrix results of the different classifications for each patient and type of kernel. Linear kernel
provides the best accuracy results for this type of sample having a lower computational cost
than the other kernels exceeding 99% of overall accuracy. This indicates that there is a strong
reliability on classifying the spectral samples of the brain surface using a supervised classifier.
Fig 8B and 8C illustrate the results of specificity and sensitivity metrics respectively with the
linear kernel for each patient and class using the One-vs-All method. As it can be seen in these
figures, the SVM classifier offers specificity and sensitivity results higher than 96%, reaching in
most cases 100% specificity and sensitivity.
Fig 9A, 9B, 9C, 9D and 9E show the synthetic RGB images generated from each HS cube
where the tumor area has been surrounded with a yellow line in each RGB image. Fig 9F, 9G,
9H, 9I and 9J show the golden standard maps generated using the labeling tool, where red,
green, blue and black colors represent the tumor tissue, normal tissue, blood vessels and back-
ground, respectively. The qualitative results generated by the supervised classifier are shown in
Fig 9K, 9L, 9M, 9N and 9O. These supervised classification maps have been obtained using the
SVM model generated from the golden standard. The color representation is the same as the
golden standard representation previously introduced, except for the blue color representing
the hypervascularized tissue presenting on the brain surface apart from the blood vessels. In
each supervised map, it is possible to identify the tumor area. Some false positives can be
found in the images. This result is produced due to the spectral similarities between the tumor
tissue and the main blood vessels or areas with extravasated blood in the surgical field as a
result of the resection. In Fig 9K, the supervised classification map of patient 1 is shown. In
this result, it can be seen that there are some false positives (delineated by an orange line)
where a main blood vessel is presented (red area in the center of the image) and near other
blood vessels far from the tumor area. Furthermore, there is another false positive in a small
region in the right bottom of the image where the bone of the skull is visible (outside of the
region where the parenchyma is exposed) due to the extravasated blood from the craniotomy.
The same effect is observed with patient 3 (Fig 9M) where there are some false positives outside
of the parenchymal area. Despite these false positives, the tumor area is clearly identifiable in
each image, and in any case blood vessels and extra-parenchymal tissue are very evident to the
surgeon during resection, so that no diagnostic confusion is likely to happen. This first step of
the cancer detection algorithm results in the approximate identification of the tumor and nor-
mal tissue areas using the SVM supervised classifier. The next step is to improve the classifica-
tion maps employing spatial information provided by the HS image.
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Improving the spatial coherence of the supervised classification maps
The supervised classification maps generated in the first step of the cancer detection algorithm
have been improved by combining these results with a one-band representation of the HS
cube using a KNN filtering method. The one-band representation of the HS image, where the
most significant information of the image is revealed, has been generated using the FR-t-SNE,
which offers a high contrast value compared to alternative dimensional reduction algorithms.
Fig 9P, 9Q, 9R, 9S and 9T present the FR-t-SNE one-band representation of each HS cube. In
these images, it is possible to identify the different areas presenting on the brain surface as
Fig 8. Quantitative results of the supervised classification performed with the SVM classifier applied to the
labeled data of each patient. (A) Overall accuracy results of supervised classification per SVM kernel type and patient.
(B) and (C) Specificity and sensitivity results obtained using the SVM classifier with linear kernel for each patient and
class employing the One-vs-All evaluation method.
https://doi.org/10.1371/journal.pone.0193721.g008
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Fig 9. Results of each step of the optimized spatial-spectral supervised classification of the five different patients. (A), (B), (C), (D) and (E) Synthetic RGB
images generated from the HS cubes. (F), (G), (H), (I) and (J) Golden standard maps used for the supervised classification training. (K), (L), (M), (N) and (O)
Supervised classification maps generated using the SVM algorithm. (P), (Q), (R), (S) and (T) FR-t-SNE one band representation of the HS cubes. (U), (V), (X), (Y)
and (Z) Spatially optimized classification maps obtained after the KNN filtering.
https://doi.org/10.1371/journal.pone.0193721.g009
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their borders are highlighted. In these one-band representations, it is possible to identify the
tumor area in each image. FR-t-SNE results together with the probability scores obtained from
the supervised classification maps are the inputs for the KNN filtering. This filtering process is
used to increase the spatial coherence of the supervised classification maps, providing the con-
textual information of each pixel in the classification scheme. Fig 9U, 9V, 9X, 9Y and 9Z illus-
trate the spatially optimized classification maps obtained after the KNN filtering process. It is
apparent that the region of each class in the images has been homogenized giving coherence to
the classification maps. Although the differences between the supervised classification maps
and the spatially optimized classification maps are not very noticeable when looking at the
resulting images by the naked eye (Fig 9K–9O and Fig 9U–9Z), this is a high important task
since this homogenization will improve the final stage of the cancer detection algorithm,
which will assign the classes to the otherwise meaningless clusters provided by the unsuper-
vised clustering algorithm. If the number of pixels that belongs to a certain class (tumor, nor-
mal, hypervascularized or background) increases or decreases in the spatially optimized
classification map, the final brain cancer classification map could be affected, showing differ-
ent densities of a certain class in a certain region delimited by the unsupervised clustering
algorithm.
Unsupervised clustering for accurate boundaries delineation of the brain
surface
Fig 10A, 10B, 10C, 10D and 10E show the segmentation maps generated for each patient
employing the HKM clustering algorithm. As it can be seen, structures such as blood vessels,
materials like the ring markers and different tissue regions are delineated by the clustering
algorithm. Furthermore, the region of interest that is formed by the parenchymal area of the
brain can be clearly differentiated. Inside this area, some different structures of tissue are
highlighted, delimiting with high accuracy the boundaries of each region. However, the infor-
mation provided by the segmentation maps is meaningless: the colors that represent each clus-
ter are randomly selected and there is no class associated for each cluster. For this reason, it is
necessary to combine the supervised identified classes with the unsupervised accurate clusters.
Delimiting and identifying the human brain area affected by cancer
The final stage of the cancer detection algorithm has the goal of combining the segmentation
map, obtained by the clustering algorithm, and the spatially homogenized classification maps,
generated after the KNN filtering process, to build the final classification map employing the
MV algorithm. Fig 10F, 10G, 10H, 10I and 10J show the MV classification map results. These
results have been generated applying the maximum majority class of the supervised classifica-
tion map to each cluster of the segmentation map. These MV maps provide more accurate
results than the spatially optimized supervised classification maps. The boundaries of each
class region are better delineated. In some cases, the tumor area is reduced, having mixed tis-
sue (normal and tumor) in the area where only tumor class was presented in the supervised
classification map (see patient 2, Fig 10G). The same effect is observed in patient 3, where
small islands of normal tissue are found to be mixed in the tumor region (see patient 3, Fig
10H). Although this MV classification map provides better delineation of the areas affected by
cancer on the brain surface, it is possible to have additional hidden information in these maps.
For example, if a cluster that represents a certain class includes a zone with a high percentage
(but not the maximum) of another class, this information is not revealed in the resulting
image. For this reason, another visualization of the MV classification map was developed, the
One Maximum Density (OMD) map. In this case, only the maximum probability results
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Fig 10. Results of each step of the proposed cancer detection algorithm applied to the five different patients. (A), (B), (C), (D) and (E)
Segmentation maps generated using the HKM algorithm. (F), (G), (H), (I) and (J) MV classification maps. (K), (L), (M), (N) and (O) OMD maps
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obtained by the MV algorithm for each cluster are used to determine the color map, and the
color of each class is then degraded using the percentage of the probability. For example, if the
probability of the tumor class for a certain cluster is 80%, the cluster color is degraded 20% (the
cluster RGB color will be R = 0.8, G = 0, B = 0). The color gradient is performed only for the
tumor tissue, normal tissue and blood vessel/hypervascularized tissue classes. The background
class is not degraded. Fig 10K, 10L, 10M, 10N and 10O show the OMD maps for each capture,
with areas of degraded color. This observation indicates that the MV result probability was
somewhat lower than for undegraded areas, and may point to the presence of different tissue
classes merged in this cluster. In order to represent the classes that are mixed in a certain cluster,
a third map is based on the three maximum probability values of the MV results in each cluster.
This representation, the Three Maximum Density (TMD) map, offers more information from
the MV results, mixing the color of each class using the percentage of the three maximum MV
probability values. For instance, if the probability of tumor class for a certain cluster is 60%, the
probability of normal tissue is 10% and the probability of blood vessel/hypervascularized tissue
is 30%, the RGB color of the cluster will be R = 0.6, G = 0.1 and B = 0.3. By employing this tech-
nique, it is possible to visualize the clusters where their respective mixed classes are hidden. Fig
10P, 10Q, 10R, 10S and 10T show the TMD maps of each capture, where clusters that are par-
tially mixed between the classes present darker colors. Patient 3 is a good example that contains
hidden information in the MV map (Fig 10H). After the generation of the TMD map (Fig 10R),
it is possible to visualize a new area surrounding the main tumor region represented in purple
color, which corresponds with hypervascularized tissue with tumor infiltration. In this case, the
system can estimate the proportion of malignant tissue that is mixed with the normal hypervas-
cularized tissue. When the tissue is classified as normal (green color), there is no mixture
between malignant and normal tissue. When there is some minimum amount of malignant tis-
sue, the proportion of malignant tissue is showed in the TMD map with a gradient of red color
and thus is marked for being resected in order to avoid tumor recurrence.
Accelerating the brain cancer detection maps generation
In order to assess the application in terms of the processing time required to analyze the HS
images during surgical procedures, Table 2 shows the results obtained from the five patient
images employed in this research. This table presents the sequential time results obtained in a
CPU implementation (using a computer with an Intel1 Core™ i7-4770k 3.5GHz) and the time
results obtained using the hardware acceleration in the spatial-spectral supervised classifica-
tion stage. Due to the connection between the computer and the hardware accelerator, a time
for the transmission is required in the accelerated version of the algorithm. However, the parti-
tion of the algorithm in both platforms allows executing the unsupervised clustering in the
CPU and the spatial-spectral supervised classification in the hardware. The total time required
for the processing in the accelerated version is computed taking into account the maximum
time obtained between the spatial-spectral supervised classification and the unsupervised clus-
tering. Specifically, when the hardware accelerator is not employed, the spatial-spectral super-
vised classification is the most time consuming stage. In contrast, an average speedup factor of
26.83x is achieved on the spatial-spectral supervised classification stage when the hardware
accelerator is used. These results show that the proposed system provides a classification map
of the captured scene during the surgery to neurosurgeons in approximately 1 minute,
depending on the size of the captured image.
that take into account only the major probability per class obtained from the MV algorithm. (P), (Q), (R), (S) and (T) TMD maps that take into
account the first three major probabilities per class obtained from the MV algorithm.
https://doi.org/10.1371/journal.pone.0193721.g010
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Discussion
The task to identify the boundary between the tumor tissue and the normal tissue that sur-
rounds is difficult for neurosurgeons by only using the naked eye, as brain tumors are
extremely infiltrative. The current tools employed to this end have many limitations to assist
in the delineation of the tumor boundaries. MRI-based neuronavigation accuracy is affected
by the brain shift during resection and depends on a questionable correlation between the
extent of enhancement on MRI and cellular infiltration. Other techniques, like 5-ALA fluores-
cence, do not work in low-grade lesions despite being highly invasive and is not recommended
for use in children. For these reasons, there is a need to develop new techniques for tumor
margin delineation in real-time, maximizing the resection of the tumor and minimizing the
resection of the adjacent normal brain. HSI offers a new possibility to address these issues,
being a non-contact, non-ionizing and non-invasive technique.
In this research work, a methodology to develop a surgical tool for identifying and delineat-
ing the boundaries of the tumor tissue using HS images has been described. For processing
these data, an active interaction between medical doctors and engineers was required. On the
one hand, medical doctors generated the HS image database and the selection of the images
where tumor tissue was present. They were also involved in the identification of certain types
of tissues, materials and substances that appear in the captured HS cubes. On the other hand,
engineers performed the digital processing of the images, developing a brain cancer detection
algorithm that exploits the spatial and spectral features of the HS images.
The preliminary results obtained in the supervised classification of the tissues that have
been previously labeled by the specialists, demonstrate that it is possible to accurately discrimi-
nate between normal tissue, tumor tissue, blood vessels and background with an overall accu-
racy higher than 99%. Using the supervised models generated with the labeled data, the entire
HS images were classified and qualitatively evaluated. Five SVM classification maps obtained
from five different patients affected by a grade IV glioblastoma tumor were generated. These
Table 2. Processing time results comparison for each patient.
Patient
ID
# Pixels Processing
Type
Pre-
processing
Transmission Spatial-Spectral Supervised
Classification
Unsupervised
Clustering
Hybrid
Classification
Total
1 251,532 Sequential (s) 14.53 0.00 482.64 45.44 0.010 542.62
Accelerated (s) 15.10 16.91 75.08
Speedup factor 1.00 0.00 28.54 1.00 1.00 7.23
2 219,232 Sequential (s) 11.34 0.00 467.47 38.97 0.008 517.79
Accelerated (s) 12.02 13.92 62.33
Speedup factor 1.00 0.00 33.57 1.00 1.00 8.31
3 185,368 Sequential (s) 10.28 0.00 321.26 33.52 0.008 365.01
Accelerated (s) 11.60 11.98 55.35
Speedup factor 1.00 0.00 26.82 1.00 1.00 6.59
4 124,691 Sequential (s) 7.22 0.00 146.63 22.26 0.005 176.11
Accelerated (s) 8.53 7.12 38.01
Speedup factor 1.00 0.00 20.58 1.00 1.00 4.63
5 189,744 Sequential (s) 14.27 0.00 268.98 33.93 0.006 317.18
Accelerated (s) 10.53 10.92 58.73
Speedup factor 1.00 0.00 24.62 1.00 1.00 5.40
The total time produced in the accelerated version is computed taking into account the maximum time obtained between the spatial-spectral supervised classification
and the unsupervised clustering.
https://doi.org/10.1371/journal.pone.0193721.t002
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maps can identify the regions where the tumor is located. Employing a spatial-spectral optimi-
zation method based on a KNN filtering and a FR-t-SNE dimensional reduction, the SVM
classification maps were spatially homogenized. A clear identification of the tumor regions
using this spatial-spectral supervised classification maps is provided. However, these maps do
not offer accurate delineation of the boundaries. The unsupervised stage of the algorithm
based on a HKM clustering method provides a segmentation map where the boundaries of 24
different regions with similar spectral characteristics are delineated. The fusion of the spatial-
spectral supervised classification map and the unsupervised segmentation map through the
MV algorithm generates the final classification map, where the boundaries of the different tis-
sues materials or substances presented in the image are identified with a certain class. In sum-
mary, the spatial-spectral classification maps allow assigning each cluster in the segmentation
map to an identifiable tissue class.
Employing the information provided by the MV algorithm, three different ways to repre-
sent the final results were analyzed. The MV map assigns the maximum probability of each
class to each cluster and represent the cluster with the correspondent color: red for tumor tis-
sue, green for normal tissue, blue for blood vessel/hypervascularized tissue and black for back-
ground. On the other hand, the OMD map displays the color of each class degraded according
to the value of the first major probability. By using this technique is possible to identify the
clusters that conform only slightly to their assigned class. Finally, the TMD map represents
each color as a combination between the different classes mixed in a certain cluster. This map
is of the most value to the operating neurosurgeon, since it offers the possibility to assess the
degree of tumor infiltration into the surrounded normal brain. This assessment is key for judg-
ing the desired extent of resection.
Finally, this complex algorithm was accelerated in order to obtain the results of the classifi-
cation in surgical-time during the neurosurgical operation. As a preliminary system, these
results are highly promising since this acceleration allows obtaining the classification results in
~1 minute depending on the size of the image, which represents an average speedup factor of
6.43x, with respect to a sequential implementation in a CPU. Compared with the intraopera-
tive pathological analysis or the intra-surgical magnetic resonance, that can take more than 30
minutes, we provide the classification result in ~1 minute, indicating the precise location of
the tumor to the operating surgeon in surgical time.
Limitations
The following relevant limitations have been found during this research: a) some false positives
have been found on the results; b) there is a need of a clinical validation of the system; c) some
misclassifications have been found between different tissues; and d) there is a need of an accel-
eration of the entire algorithm. Next, these limitations are detailed together with some possible
solutions.
False positives have been encountered in the obtained results that could be solved with fur-
ther investigations. For instance, there are some misclassifications between blood or blood ves-
sels and tumor tissue due to the high intra-class variability between the vascularized tissues,
although these false positives do not affect the area of identified tumor so that the margins of
the tumor remain clearly evident. The use of an increased database to generate the supervised
classification model, where the inter-patient variability is taken into account, is expected to
produce better classification results. The inclusions of more labeled samples of normal tissue
will reduce the occurrence of false positives in the results.
Furthermore, an extensive clinical validation is required to validate if the boundaries of the
tumor area represented in the TMD map are accurately identified. Several biopsies of the
Hyperspectral brain cancer imaging classification
PLOS ONE | https://doi.org/10.1371/journal.pone.0193721 March 19, 2018 22 / 27
boundaries of tumor area must be obtained and analyzed by the pathologists to certify the
brain cancer algorithm results.
On the other hand, there are some misclassifications between different tissues with high
vascularization. In some cases, extravasated blood and normal tissue affected by edema were
classified as blood vessel/hypervascularized tissue (blue color). This misclassification is pro-
duced due to the similar spectral characteristics of the blood vessels and the tissue affected by
edema. Further investigations where these spectral differences are included in the training of
the brain cancer algorithm could alleviate this problem, or perhaps a new class could be cre-
ated to identify the normal brain with high vascularization.
Finally, further investigations in the algorithm acceleration could provide the final TMD
map in less than one second by using heterogeneous high performance computing system,
thus obtaining real-time results. The future of this intraoperative HSI system is envisioned
employing snapshot HS cameras, which can capture about ten images per second, allowing
even tracking dynamic changes of the tissues.
Conclusions
This study develops a brain cancer detection algorithm to classify HS images of brain tumor in
surgical-time during neurosurgical operations. It has been demonstrated that the use of HSI as
a new non-invasive surgical-time visualization tool can improve the outcomes of the undergo-
ing patient, assisting neurosurgeons in the resection of the brain tumor. The identification of
the tumor boundaries and the tumor infiltration into normal brain is highly relevant in order
to avoid excessive resection of normal brain and to avoid unintentionally leaving residual
tumor. Currently, further investigations are being carried out by the research team in order to
generalize the results obtained, to optimize the algorithms and validate their findings, as well
as to increase the image database and optimize the acquisition system. Furthermore, the use of
other hardware acceleration platforms (such us GPUs or FPGAs) are currently under consid-
eration to implement the full brain cancer detection algorithm. Such implementation must
explore the design space to achieve the best tradeoff between real-time execution, memory
usage and power dissipation using heterogeneous platforms. This next generation of medical
HSI systems could offer neurosurgeons a real-time visualization tool to assist them during the
entire process of the tumor resection providing several TMD maps per second.
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